Search Results - "Rathouska, J."

The evaluation of endoglin, vcam-1 and p-selectin expression and co-expression in aortas of apoe-deficient mice – An immunohistochemical study by Rathouska, J, Jezkova, K, Nemeckova, I, Nachtigal, P

Get full text

Soluble endoglin and markers of endothelial function/dysfunction in mouse aorta – A pilot study by Jezkova, K, Rathouska, J, Nemeckova, I, Nachtigal, P

Get full text

Atorvastatin-induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin by Zemankova, L, Varejckova, M, Dolezalova, E, Fikrova, P, Jezkova, K, Rathouska, J, Cerveny, L, Botella, L M, Bernabeu, C, Nemeckova, I, Nachtigal, P

“…Endoglin, a transforming growth factor β (TGF-β) receptor type III, is co-expressed with endothelial nitric oxide synthase (eNOS) in aortic endothelium in…”
Get more information

Effects of atorvastatin treatment on endoglin and enos expression in endothelial cells by Zemankova, L, Varejckova, M, Jezkova, K, Nemeckova, I, Rathouska, J, Nachtigal, P

Get full text

High levels of soluble endoglin induce inflammation and oxidative stress in aorta compensated with preserved no-dependent vasodilatation mice fed high fat diet by Jezkova, K, Rathouska, J, Nemeckova, I, Fikrova, P, Dolezelova, E, Varejckova, M, Vitverova, B, Bernabeu, C, Novoa, J.M, Chlopicki, S, Nachtigal, P

Get full text

Vascular/Endothelial Dysfunction Is Related To Altered Endoglin Expression And Signaling In Hypercholesterolemic Mice by Vitverová, B., Blazickova, K., Rathouska, J., Vicen, M., Nachtigal, P.

Get full text

Antioxidants and vitamins in clinical conditions by Zadák, Z, Hyspler, R, Tichá, A, Hronek, M, Fikrová, P, Rathouská, J, Hrnciariková, D, Stetina, R

“…Various reactive oxygen species (ROS) may be produced from normal biochemical, essential metabolic processes or from external sources as exposure to a variety…”
Get full text

Liver fibrosis development affects tissue and soluble endoglin in mice by Eissazadeh, S., Faradonbeh, F. Alaei, Sá, I. A. Igreja, Němečková, I., Tripská, K., Vašinová, M., Vitverová, B., Rathouská, J., Nachtigal, P.

Get full text

Anticonvulsant effects of bretazenil (Ro 16-6028) during ontogenesis by Kubová, H, Rathouská, J, Mares, P

“…Anticonvulsant action of a new benzodiazepine, bretazenil (Ro 16-6028), was studied in 240 rats in five age groups: age 7, 12, 18, 25 and 90 days. Motor…”
Get more information

Anticonvulsant activity of flumazenil in rats during ontogenetic development by Rathouská, J, Kubová, H, Mares, P, Vorlícek, J

“…The influence of flumazenil on seizures induced by pentylenetetrazol (PTZ) was studied in rats aged 7, 12, 18, 25, and 90 days. Flumazenil in doses of 25,…”
Get more information

95 ATORVASTATIN INCREASES CHOLESTEROL LEVELS IN APOE/LDLR-DEFICIENT MICE by Slanarova, M., Brcakova, E., Vecerova, L., Strasky, Z., Rathouska, J., Hyspler, R., Ticha, A., Nachtigal, P.

Get full text

409 CHANGES OF ENDOGLIN LEVELS IN SERUM AND MICE AORTA WITH RESPECT TO CHOLESTEROL AND ATORVASTATIN by Večeřová, L., Strasky, Z., Rathouska, J., Slanarova, M., Brcakova, E., Nachtigal, P.

Get full text

418 ENDOGLIN-RELATED PATHWAYS ARE NOT RELATED TO DISTINCT PREDISPOSITION TO ATHEROSCLEROSIS IN C57BL/6J AND C3H/HEJ MICE by Rathouska, J., Strasky, Z., Vecerova, L., Brcakova, E., Slanarova, M., Nachtigal, P.

Get full text

P424 ENDOGLIN (TYPE III TGF-β1 RECEPTOR), BAD OR GOOD IN ATHEROSCLEROSIS? by Nachtigal, P., Strasky, Z., Vecerova, L., Brcakova, E., Slanarova, M., Rathouska, J., Micuda, S.

Get full text

P412 PLEIOTROPIC EFFECTS OF ATORVASTATIN AND TGF-β/ENDOGLIN CASCADE IN THE VESSEL WALL OF ApoE/LDLR DOUBLE KNOCKOUT MICE by Strasky, Z., Vecerova, L., Slanarova, M., Rathouska, J., Brcakova, E., Micuda, S., Nachtigal, P.

Get full text

P407 ENDOGLIN EXPRESSION IN ATHEROGENESIS IS NOT RELATED TO EITHER CHOLESTEROL LEVELS OR PLAQUE SIZE IN ApoE/LDLR DOUBLE KNOCKOUT MICE by Vecerova, L., Strasky, Z., Rathouska, J., Slanarova, M., Brcakova, E., Micuda, S., Nachtigal, P.

Get full text